Celanese Corporation - CE STOCK NEWS

Celanese Corporation (NYSE: CE) reported record net sales of $2.5 billion for Q1 2022, reflecting a 12% increase sequentially. GAAP diluted EPS stood at $4.61, and adjusted EPS was $5.54, surpassing previous records by 10%. The company achieved an operating profit of $531 million and adjusted EBIT of $713 million. Celanese is poised for further growth after announcing a $11 billion acquisition of DuPont's Mobility & Materials business, expected to double annual free cash flow. The company forecasts Q2 adjusted earnings at approximately $4.50 per share.

Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share on its common stock, with a payment date set for May 12, 2022. This dividend is available to stockholders of record as of April 28, 2022. In 2021, Celanese reported net sales of $8.5 billion.

Celanese Corporation has successfully restructured its joint venture with Mitsubishi Gas Chemical Company, focusing on its Korea Engineering Plastics Co. (KEP). This restructuring allows KEP to manufacture and supply products independently, enhancing access to original equipment manufacturers and markets outside of China. The restructuring is expected to provide immediate financial benefits with an increase in adjusted EBIT of $25-$40 million and an EPS accretion of $0.15-$0.20 over three years.

Celanese Corporation (NYSE: CE) will host a conference call on April 29, 2022, at 10:00 a.m. Eastern time to discuss its first quarter results. The earnings press release will be available on April 28, 2022, after market close. Interested parties can join the call via webcast or phone, with a replay accessible from April 29 to May 13, 2022. Celanese, a leader in chemical and specialty materials, reported $8.5 billion in net sales for 2021 and employs around 8,500 people worldwide.

DuPont has entered into a definitive agreement to divest a majority of its Mobility & Materials segment to Celanese Corporation for $11 billion. This transaction values the business at an enterprise multiple of approximately 14x 2021 operating EBITDA. The divested businesses generated $3.5 billion in net sales and $0.8 billion in operating EBITDA in 2021. The deal, anticipated to close by the end of 2022, marks a significant step in DuPont's transformation strategy and is expected to generate substantial value for shareholders. Additionally, DuPont plans to sell the Delrin® business by Q1 2023.

Celanese (NYSE: CE) has announced the acquisition of a majority of the Mobility & Materials business from DuPont for $11.0 billion. This strategic move aims to position Celanese as a leading global specialty materials company, generating approximately $450 million in synergies and providing immediate accretion to adjusted EPS. The deal will significantly enhance cash flow, with total debt projected to drop below 3.0x EBITDA within two years. Completion is anticipated by the end of 2022, pending regulatory approvals.

Celanese Corporation (NYSE: CE) has elected Rahul Ghai and Michael Koenig to its Board of Directors, expanding the board to eleven members, ten of whom are independent. Ghai, previously with Otis Worldwide Corporation, brings extensive financial expertise, while Koenig, CEO of Nobian Industrial Chemicals, adds significant materials manufacturing experience. Both will serve immediately and stand for re-election at the 2022 Annual Meeting of Shareholders. This strategic addition aims to enhance Celanese's leadership and support its global growth initiatives.

Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share on its common stock, scheduled for payment on March 8, 2022. Shareholders of record as of February 22, 2022 will receive this dividend. In 2021, Celanese reported net sales of $8.5 billion.

Celanese Corporation reported record GAAP diluted earnings per share of $17.06 and adjusted EPS of $18.12 for 2021, supported by net sales of $8.5 billion, a 51% increase from 2020. The company effectively countered $1.1 billion in inflationary costs, achieving an operating profit of $1.9 billion. In Q4, GAAP diluted EPS was $4.83, with net sales reaching $2.3 billion. The outlook for 2022 forecasts adjusted earnings of $15.00 per share, reflecting strong demand despite ongoing supply chain challenges.